MMIT’s Annual State of the Industry Survey
In an attempt to shed light on the current and future patient access landscape, we conduct a comprehensive industry survey alongside our sister company, The Dedham Group. Our goal is to better understand how pharma leaders today are planning for potential access problems tomorrow.
By sharing these insights and our key perspectives on what it all means, our hope is to equip companies with the information they need to power their commercial decision-making—and ensure the right patient gets access to the right treatment at the right time.
Below, you’ll find previous years’ resources from our annual industry research.
Ready to Learn More?
2025
Research Report
The State of Patient Access 2025
Learn the key findings from our survey along with in-depth analysis of what pharma companies need to know to improve their access strategies.
Executive Summary
Maximizing Access Strategies in the Era of Biosimilars
Explore the most compelling survey findings—and key expert insights—in this Biopharma Dive Executive Summary.
WEBINAR
How to Overcome Market Access Challenges in the Era of Biosimilars
In this webinar, hosted by Biopharma Dive, the authors explore key insights from the survey and how brands are rethinking their strategies in response to market changes.
ARTICLE
Patient Access Barriers in 2025 and Beyond
In this blog, authors Steve Callahan and Hannah Baxter discuss the most compelling findings from our industry survey—and how they might affect market access planning for years to come.
INFOGRAPHIC
The Future of Biosimilar Development
Learn which market factors are spurring manufacturers to invest in new biosimilar development.
2024
RESEARCH REPORT
The State of Patient Access 2024
Learn the key findings from our survey along with in-depth analysis of what pharma companies need to know to improve their access strategies.
INFOGRAPHIC
Overcome Unique Access Barriers
Here's a look at the six therapeutic areas that are generating the most excitement from industry leaders, and the anticipated hurdles to access.
WEBINAR
Overcoming the Barriers to Patient Access
In this BioPharma Dive webinar, experts from MMIT and The Dedham Group share the results of the 2024 State of Patient Access Survey and explain how companies are navigating these complex access challenges.
ARTICLE
Understanding Access Barriers in 2024 and Beyond
In this blog, you’ll get the highlights from our survey along with the five key patient access issues that are top of mind for pharma and biotech execs, from increasing payer restrictions to regulatory concerns to exciting yet unknown emerging technologies.
INFOGRAPHIC
Reliance on Real-World Data Across the Product Lifecycle
Our findings show that 72% of pharma companies use real-world data to diagnose market access issues and prioritize interventions.